Recommendation ID
NG231/02
Question

Frequency and duration of endoscopic surveillance: What is the usefulness of clinical and molecular biomarkers to inform the optimal frequency and duration of endoscopic surveillance for adults with Barrett's oesophagus?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made this recommendation for research, see the rationale section on endoscopic surveillance.

Full details of the evidence and the committee's discussion are in evidence review F: frequency and duration of endoscopic surveillance techniques.


Source guidance details

Comes from guidance
Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management
Number
NG231
Date issued
February 2023

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 28/02/2023